Načítá se...

Preclinical Development of Inactivated Rabies Virus–Based Polyvalent Vaccine Against Rabies and Filoviruses

We previously described the generation of a novel Ebola virus (EBOV) vaccine based on inactivated rabies virus (RABV) containing EBOV glycoprotein (GP) incorporated in the RABV virion. Our results demonstrated safety, immunogenicity, and protective efficacy in mice and nonhuman primates (NHPs). Prot...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Infect Dis
Hlavní autoři: Willet, Mallory, Kurup, Drishya, Papaneri, Amy, Wirblich, Christoph, Hooper, Jay W., Kwilas, Steve A., Keshwara, Rohan, Hudacek, Andrew, Beilfuss, Stefanie, Rudolph, Grit, Pommerening, Elke, Vos, Adriaan, Neubert, Andreas, Jahrling, Peter, Blaney, Joseph E., Johnson, Reed F., Schnell, Matthias J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4564550/
https://ncbi.nlm.nih.gov/pubmed/26063224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiv251
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!